Fidelity International’s Caribou Biosciences CRBU Stock Holding History

Fidelity International’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-860,666	Closed	-$1.37M	–	924
2024 Q4	$1.37M	Hold	860,666	–	–	﹤0.01%	707
2024 Q3	$1.69M	Hold	860,666	–	–	﹤0.01%	701
2024 Q2	$1.41M	Hold	860,666	–	–	﹤0.01%	707
2024 Q1	$4.42M	Hold	860,666	–	–	﹤0.01%	605
2023 Q4	$4.93M	Hold	860,666	–	–	0.01%	575
2023 Q3	$4.11M	Hold	860,666	–	–	﹤0.01%	571
2023 Q2	$3.66M	Hold	860,666	–	–	﹤0.01%	593
2023 Q1	$4.57M	Hold	860,666	–	–	0.01%	577
2022 Q4	$5.4M	Hold	860,666	–	–	0.01%	574
2022 Q3	$9.08M	Hold	860,666	–	–	0.01%	505
2022 Q2	$4.67M	Sell	860,666 -1	-0%	-$8	0.01%	601
2022 Q1	$7.9M	Hold	860,667	–	–	0.01%	560
2021 Q4	$13M	Hold	860,667	–	–	0.01%	505
2021 Q3	$20.5M	Buy	+860,667	New	+$21M	0.02%	432

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International's CRBU Position: Q1 2025 in Review

Fidelity International sold out of Caribou Biosciences (CRBU) in Q1 2025, closing a stake of 860,666 shares — an estimated $1.37M sold.

Fidelity International first reported a position in CRBU in Q3 2021 and held it in 14 quarters. The position peaked at $20.5M in Q3 2021. 131 funds tracked by Wall St. Rank hold CRBU as of Q1 2025.

Fidelity International reported no remaining Caribou Biosciences position as of Q1 2025 after selling out during the quarter.
Fidelity International sold 860,666 Caribou Biosciences shares in Q1 2025, an estimated $1.37M.
Fidelity International first reported a position in Caribou Biosciences in Q3 2021 and held it in 14 quarters.
Fidelity International's Caribou Biosciences position peaked at $20.5M in Q3 2021.
131 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2025.

Based on Fidelity International's 13F filing for Q1 2025, filed 12 May 2025.